Company / EPS (Diluted)
Sonoma Pharmaceuticals, Inc. EPS (Diluted) History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.79
FY2026
5-year range
-$10.63 / -$1.52
FY2022-FY2026
Trend
+73.8%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 9 years, ranging from $-28.49 in FY2019 to $2.20 in FY2018.
Based on SEC 10-K filings.
-2.79 in FY2026.
Declined from $-1.52 to $-2.79 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, eps (diluted) increased 73.8% year-over-year.
- Peak eps (diluted) was recorded in FY2018.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | -$2.79 | +73.8% |
| FY2025 | -$10.63 | -599.3% |
| FY2024 | -$1.52 | +20.8% |
| FY2023 | -$1.92 | - |
| FY2022 | - | - |
| FY2021 | -$2.24 | +82.5% |
| FY2020 | -$12.77 | +55.2% |
| FY2019 | -$28.49 | -1395.0% |
| FY2018 | $2.20 | +171.2% |
| FY2017 | -$3.09 | -263.5% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026